There is still much difficulty in elucidating the aetiological causes of dwarfism as it presents itself in children. After Erdheim in 1916 attributed dwarfism to a lack of pituitary secretion, it was for many years a common habit to implicate a pituitary deficiency in alJ dwarfs whatever their clinical features. A reaction to this unscientific approach was to be expected, and it has been so extreme in some quarters (Horstmann, 1950 ) that a pituitary origin for any type of dwarfism has been denied. Such a reaction is only possible if one contends that the enormous body of experimental work demonstrating the presence of an anterior pituitary growth hormone has no application to man, if one ignores the clinical pictures of dwarfism associated with destruction of the anterior pituitary, if one forgets the few reports of post-mortem examination in dwarfs which have demonstrated a deficiency of eosinophil cells in the anterior pituitary (Hewer, 1944) , if one overlooks the clinical pictures of gigantism and acromegaly, and if one prefers not to remember that the absence of most hormones in the body is represented by a specific clinical syndrome. This aetiological nihilism, therefore, entails a denial of established fact which is too complete for most observers; but a moderate conservatism demands that some evidence of hypopituitarism should be forthcoming in any case of dwarfism before a diagnosis of pituitary dwarfism is made.
In the attempt to establish the aetiology of dwarfism in the individual child, all the systemic causes of infantilism and all the bone diseases which can produce short stature must be excluded. There are then two questions which urgently require an answer, Is this child suffering from hypothyroidism ? Is there organic disease in the region of the pituitary ? The clinical picture of cretinism is well recognized, but continued observation may be necessary to establish the diagnosis of juvenile myxoedema. If an arrest of growth can be shown not to be due to disease or malnutrition, then hypothyroidism should be suspected, and the signs of diminished vitality, cold extremities, slow pulse, electrocardiographic abnormalities, raised blood cholesterol level, and low basal metabolic rate must be looked for. Gross destruction of the pituitary by tumour, by xanthomatosis or by inflammation is rare in children, and a craniopharyngioma as a cause of dwarfism is very uncommon. When these infrequent causes are excluded, there remains a large group of children in whom a cause for their dwarfism has still to be sought, and among them will be examples of pituitary dwarfism.
The separation of the cases of pituitary dwarfism due to the absence of the growth hormone would be simple if it were possible to assay the level of growth hormone in the blood or to determine the quantity of its metabolized products in the urine. However, no such investigations are as yet possible, and to determine whether dwarfism is related to a deficiency of the growth hormone, it is necessary to depend on a clinical picture of pituitary dwarfism, It must be assumed that the 'primordial' dwarfs grow to a height genetically determined; whether or not these primordial dwarfs are an example of a diminished sensitivity of the end organ, in this case all the somatic tissues, in the presence of normal or increased amounts of the specific hormone, cannot be decided in the absence of assays of the growth hormone. The most commonly occurring example of the primordial dwarf is the so-called Lorain dwarf. Here the height age is less than in hypopituitary dwarfism, but the bone age is within average limits. In other respects, except in a failure to grow, development is perfect and there is no persistence of the infantile facial appearance. The group of genetic dwarfs also includes those girls and women who suffer from ovarian agenesis in association with other congenital defects. In the group of dwarfs showing delay of epiphyseal development and fusion (hypothyroidism already excluded) are the pituitary dwarfs and also children whom Wilkins (1950) described as showing delayed adolescence. This last group show a consistent delay of two to four years in their epiphyseal development, and in their early 'teens fail to show the normal spurt in growth and sexual development. The spurt comes at a late age, and they may never attain average height. It appears probable that this is a heterogeneous group, in some of whom the peculiar pattern is genetically determined, while in others the delayed growth is the result of environmental factors. In either case, the delayed epiphyseal development may indicate relative deficiency of the growth hormone or diminished sensitivity of the skeleton to its stimulus. The genetic cases may be associated with a disturbance of the normal growth hormone: androgen ratio. Talbot (1945) , and Talbot, Sobel, Burke, Lindemann, and Kaufman (1947) A radiograph of the bones showed that the pituitary fossa was normal. There was no epiphyseal dysgenesis.
All bones of the carpus (except the pisiform), and the head of the radius and patella were present. The distal epiphyses of the ulna (Fig. 3) and internal epicondyle of the humerus were absent. Bone age was therefore between 5 and 6 years.
The insulin sensitivity test (Fig. 4) g. % (serum albumin 4 4 g. %, and serum globulin 3-2 g. %).
The insulin sensitivity test (Fig. 7 May 16, 1950,. were less than 6 M.U. in 24 hours; on June 18, 1950, they were 2 M.U. in 24 hours.
Radiographs after a barium meal showed a normal small intestine pattern. The pituitary fos7sa was normal in outline; there was generalized osteoporosis of the skeleton (Fig. 8) , and a marked delay of epiphyseal fusion with a bone age of 17 to 18 years (Fig. 9) .
The blood count was normal. Eosinophil polymorphs were 5% of 8,200 W.B.C.s per c.mm. The response of eosinophils to adrenaline (0 3 mg. subcutaneously) was not outside normal limits.
A testicular biopsy (Dr. G. R. Osborn) showed that the seminiferous tubules had a normal basement membrane (Fig. 10) . The cells were nearly all of the Sertoli type. Small numbers of early sex cells (spermatogonia) were present, but very few had mitotic figures and no differentiation to later types was seen. The spermatogonia had much larger nuclei than the Sertoli cells. In the interstitial tissue there appeared to be a total absence of Leydig cells. This was in striking contrast to the atrophic undescended testis. Treatment by chorionic gonadotropins produced no increase in the size of the testes. Treatment by methyl-testosterone (20 mg. b.d.) caused increased growth of axillary and pubic hair. The facial hair grew, and it became necessary for the patient to shave once a week. The penis increased in size, but the testicles showed no alteration in size. He had occasional erections, but no seminal emission as a result of treatment. His voice deepened and both his habitus and his outlook became more masculine.
Discussion
The boy T.B., aged 71 years, showed the clinical appearance of a pituitary dwarf, but the diagnosis of pituitary dwarfism should not be considered probable unless (1) cretinism or myxoedema is excluded, (2) the height is at least 20% below the average for coevals, (3) the bone age, after the age of 5 years, is at least two years behind coevals, (4) the ratio of upper to lower segment corresponds approximately to the 'chronological ' age (proportionate dwarf), and (5) The diagnosis of hypopituitarism in D.T. is confirmed by the low gonadotropin urinary excretion (less than 6 M.U. while the normal is 6-50 M.U. in 24 hours). The excretion of 17-ketosteroids (9-10 mg. in 24 hours before testosterone therapy) represents the normal product of adrenal androgens. The scarcity of Leydig cells in the testis gave histological support to the clinical diagnosis of absent testicular androgens (representing one-third of the 17-ketosteroid excretion) as evidenced by the eunuchoid habitus (low upper to lower segment ratio and span greater than height), the sparseness and absence of sexual hair, the delayed epiphyseal fusion and the generalized osteoporosis. Osteoporosis of the degree seen in D.T.'s skeleton is rare in hypopituitarism, although it is well explained by the absence of testicular androgens (Albright and Reifenstein, 1948) . In their absence there is a defect in the deposition of osteoid tissue while resorption of bone proceeds normally.
The insulin sensitivity test was normal in both subjects, except that in T.B. there was some diminished response to hypoglycaemia. Although this was shown to be present in subsequent tests, it is doubtful if it can be interpreted as evidence for the absence of an anti-insulin factor (? growth hormone).
The purified growth hormone causes neither nitrogen retention in normal individuals nor does it enhance growth in pituitary dwarfs (Bennett, Weinberger, Escamilla, Margen, Li, and Evans, 1950 ) and yet no inhibitors to its action in the blood were demonstrated by these observers. The advisability of the treatment of pituitary dwarfism in children before puberty by testosterone is debatable. The arguments against it are that the testes may thereby be damaged, and that the ultimate height of the child will not be increased by such therapy. It is possible to damage the testis after puberty by testosterone therapy, but there is no evidence that this occurs before puberty. In men after daily doses of 25 mg. of testosterone propionate over long periods (24-91 days) it has been shown that the testicular changes are completely reversible (Heller, Nelson, Hill, Henderson, Maddock, and Jungck, 1950) . There is one biopsy report in the literature (Talbot, 1945) in which testosterone was administered to a boy in interrupted courses between 13 and 16 years of age, and testicular biopsy at 16 years showed no evidence of damage. There can be no proof that testosterone will not increase the ultimate height of a pituitary dwarf. Providing it is not used in children whose bone age is normal (e.g. non-pituitary dwarfs), and providing the child's bone age is not accelerated beyond the normal for its age, it seems reasonable to employ 538 ARCHIVES OF DISEASE IN CHILDHOOD testosterone in therapy, using it in interrupted courses, and with adequate radiographical control.
Summary and Conclusions
The difficulties of distinguishing pituitary dwarfs before the age of puberty from the other types of dwarfism-whether ' primordial,' genetic or acquired -are considered.
Criteria are suggested for the clinical diagnosis of pituitary dwarfism of which the most important are the persistence of an immature facies, the retardation of bone age by at least two years, and a height which is at least 20% below the average for coevals in the proven absence of hypothyroidism.
Two male first cousins are described, in one of whom, aged 71 years, pituitary dwarfism was present and in the other, aged 20 years, pituitary hypogonadism, with deficient urinary excretion of gonadotropins, testicular hypoplasia, eunuchoid habitus, defective secondary male sexual characters, osteoporosis with retarded union of epiphyses, could be demonstrated. It is suggested that when other treatments have failed it is justifiable to use methyl-testosterone therapy after the age of puberty in pituitary hypogonadism, and before the age of puberty in pituitary dwarfism. In the latter case care must be exercised not to advance the child's bone age beyond the chronological age so that early epiphyseal closure is avoided.
